Lantheus soars 15% on Q1 beat, beats Q2 and FY forecast estimates
CharlieAJA/iStock via Getty Images
- Lantheus (NASDAQ:LNTH) surges 15% on better-than-expected Q1 results, driven by PSMA PET with Pylarify and Definity's increasing utilization for diagnostic purposes.
- The company expects Q2 FY 2023 revenue to be between $300M to $310M, beating the consensus estimate of $286.12M. Additionally, Q2 FY 2023 adjusted diluted EPS is projected to be between $1.25 to $1.33, higher than the consensus estimate of $1.21.
- Lantheus FY 2023 Revenue Guidance: $1.23B-$1.27B, beating the $1.16B consensus estimate. FY 2023 Adjusted Fully Diluted EPS Guidance: $5.45-$5.70, surpassing the $5.00 consensus estimate.
- Lantheus reports Q1 revenue of $300.78M, up 44% YoY, beats by $20.12M and Non-GAAP EPS of $1.47, exceeding expectations by $0.18.
- Press Release